对比增强超声对既往影像学不确定肾病变的分类价值
该回顾性诊断准确性研究纳入2006至2015年在本三级医院行肾脏对比增强超声检查的患者,比较增强超声与既往影像对病变的定性能力,以组织学检查和随访(平均3.63年)为最终诊断,结果显示既往CT、MRI或常规超声不确定的病变中95.7%(90/94)可经增强超声成功分类。
要点
- 既往CT、MRI或常规超声不确定的肾病变中,95.7%(90/94)可经对比增强超声成功分类。
- 对比增强超声诊断敏感度100%(20/20),特异度85.7%(18/21),准确率90.2%(37/41)。
- 对比增强超声阴性预测值100%(18/18),阳性预测值87.0%(20/23)。
核心结论
- 对比增强超声对CT、MRI或常规超声无法定性的肾病变有较高可能做出明确分类。
研究设计与样本
- 经机构审查委员会批准的回顾性诊断准确性研究,纳入2006至2015年本三级医院所有行肾脏对比增强超声检查的患者,共评估134个病变,其中106个既往影像不确定,仅纳入每位患者最大病变进行分析;以组织学检查和随访(平均3.63年)为最终诊断。
诊断标准与关键数值
- 对比增强超声对既往不确定肾病变的敏感度为100%(20/20;95%CI 83%-100%;P<.0001)。
- 对比增强超声的特异度为85.7%(18/21;95%CI 62%-97%;P=.0026)。
- 对比增强超声的阳性预测值为87.0%(20/23;95%CI 66%-97%;P=.0005)。
- 对比增强超声的阴性预测值为100%(18/18;95%CI 81%-100%;P<.001)。
- 对比增强超声的准确率为90.2%(37/41;95%CI 80%-98%;P<.0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine the utility of contrast-enhanced ultrasound (US) for characterizing renal lesions that were indeterminate on prior imaging.
METHODS: This Institutional Review Board-approved retrospective diagnostic accuracy study evaluated all patients who underwent renal contrast-enhanced US examinations from 2006 to 2015 at our tertiary care hospital. We compared the number of lesions definitively characterized by contrast-enhanced US with the indeterminate lesions by prior imaging. The accuracy of contrast-enhanced US was compared with the final diagnosis by histologic examination and follow-up (mean, 3.63 years). Accuracy and agreement estimates were compared with the exact binomial distribution to assess statistical significance.
RESULTS: A total of 134 lesions were evaluated with contrast-enhanced US, and 106 were indeterminate by preceding computed tomography, magnetic resonance imaging, or US. Only the largest lesion per patient was included in analysis. A total of 95.7% (90 of 94) of the previously indeterminate lesions were successfully classified with contrast-enhanced US. The sensitivity was 100% (20 of 20; 95% confidence interval [CI], 83%-100%; P < .0001); specificity was 85.7% (18 of 21; 95% CI, 62%-97%; P = .0026); positive predictive value was 87.0% (20 of 23; 95% CI, 66%-97%; P = .0005); negative predictive value was 100% (18 of 18; 95% CI, 81%-100%; P < .001); and accuracy was 90.2% (37 of 41; 95% CI, 80%-98%; P < .0001).
CONCLUSIONS: Contrast-enhanced US has a high likelihood of definitively classifying a renal lesion that is indeterminate by computed tomography, magnetic resonance imaging, or conventional US.
引用
- Zarzour JG, Lockhart ME, West J, et al. Contrast-Enhanced Ultrasound Classification of Previously Indeterminate Renal Lesions. J Ultrasound Med. 2017. PMID: 28429490. doi:10.1002/jum.14208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。